- A Phase III Study Assessing the Addition of Atezolizumab Immunotherapy to the Usual Radiation Treatment for Patients with Early Non-Small Cell Lung Cancer – On Cancer – Memorial Sloan Kettering
- NANOBIOTIX Announces Four Presentations at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting – BioSpace
- Science Talk – Immunotherapy goes viral: ICR research on cancer-killing viruses featured on BBC’s The One Show – The – The Institute of Cancer Research
-(1)-300x169.jpg)
- Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing – PRNewswire
- Global T-Cell Immunotherapy Markets 2020-2025 by Mechanism Of Action, Type of Therapy, Product Class – Yahoo Finance
- A Phase II Study of Ipilimumab and Nivolumab Immunotherapy plus Cabozantinib to Treat Rare Advanced Genitourinary Cancers – On Cancer – Memorial Sloan Kettering
- FIP200 Deletion May Enhance Response to Immunotherapy in Breast Cancer – OncLive
